News

The Food and Drug Administration Oct. 15 removed epinephrine from the lists of drugs authorized for temporary compounding during the COVID-19 public health emergency by outsourcing facilities and state-licensed pharmacies or federal facilities not registered as outsourcing facilities.

The Centers for Medicare & Medicaid Services Oct. 15 said it will incentivize labs to deliver quicker results to patients undergoing COVID-19 diagnostic testing.

The Department of Health and Human Services announced agreements with CVS and Walgreens to provide and administer COVID-19 vaccines to long-term care facility residents.

Hospitals and health systems have reinvented themselves in many ways to respond to COVID-19. Since March, decades of standard operating procedures have been reexamined, redesigned and refined — all with the goal of saving lives while protecting caregivers and patients’ families during the pandemic.

The AHA Oct. 21 at noon ET will host a webinar featuring leaders from Henry Ford Health System, Ascension Wisconsin and Loyola University Chicago’s Stritch School of Medicine discussing their approaches to addressing community and population health as the field moves from pandemic response to recovery to rebuilding.

A federal appeals court in Washington, D.C., heard oral argument in an appeal from the AHA and hospital groups to overturn a Department of Health and Human Services rule requiring hospitals to disclose their confidential privately negotiated charges with insurers.

The AHA’s American Society for Health Care Engineering Oct. 7 awarded its 2020 Energy Champion Award for outstanding leadership in energy efficiency to The Atrium Health Cleveland in Shelby, N.C.

A new study published Oct. 14 in JAMA Cardiology is highlighting flaws in the Centers for Medicare & Medicaid Services’ Hospital Readmission Reduction Program that resulted in inappropriate penalties on hospitals or, in some cases, overlooking hospitals that should have been penalized.

The Food and Drug Administration Oct. 14 approved Inmazeb for treating Zaire ebolavirus infection in adult and pediatric patients.

In part three of a Value Rounds series on working toward value together, leaders from Northwell Health and Atrium Health's Carolinas Medical Center discuss the role of health care providers — from the front lines to leadership — in improving outcomes, enhancing the patient experience and reducing cost. Robyn Begley, AHA senior vice president and chief nursing officer and CEO of American Organization for Nursing Leadership, moderated the podcast.

The American Medical Association’s annual review of U.S. health insurance markets indicates an erosion of competition and choice for many patients, particularly in markets where it is most scarce.

Medicaid enrollment for fiscal year 2021 is expected to jump 8.2%, with state spending to accelerate by 8.4%, according to data from 42 state Medicaid directors and compiled by the Kaiser Family Foundation.

The Federal Reserve will host a webinar Oct. 21 at 2 p.m. ET to help borrowers learn about the Main Street Lending Program and provide an opportunity for borrowers to get answers to specific questions on the program and its operations. Questions are to be submitted in advance to questions@askthefed.org by Oct. 16 at 5 p.m. ET. 

The Centers for Medicare & Medicaid Services announced that it has expanded the list of telehealth services that Medicare will pay for during the COVID-19 public health emergency.

Hospital and health system trustees are promoting value in their communities by tackling societal factors that influence the health and well-being of residents.

The AHA, the American Medical Association and American Nurses Association urged President Trump to rescind Executive Order 13950, Combating Race and Sex Stereotyping, arguing that failing to do so “would effectively reverse decades of progress in combating racial inequality.”

The Department of Health and Human Services and the Department of Defense awarded $481 million to Cue Health Inc. to expand production of a point-of-care COVID-19 molecular test with capabilities to produce results in 20 minutes.

The National Institutes of Health Oct. 13 announced a study designed to identify promising COVID-19 therapies and investigational drugs that merit larger clinical trials.

The Centers for Disease Control and Prevention added vaccine information to its COVID-19 webpage.

The Food and Drug Administration Oct. 13 issued and immediately implemented enforcement policy for modifications to FDA-cleared molecular influenza and RSV tests during the COVID-19 public health emergency to expand access to certain FDA-cleared molecular tests for detecting and identifying flu viruses and respiratory syncytial viruses.